Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
Globe Newswire•10/08/2026•08:00 ET
0
Whiz Insights
SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below:
Canaccord Genuity 46th Annual Growth Conference Date: Wednesday, August 12, 2026 at 2:30pm E.T. Location: Boston, MA Presenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas Maestas Format: Presentation and 1x1 Meetings
Get started
Create a free account to read the full story.